Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KIF11 | P52732 | 7/20 | 0.40 |
| ▸ | NPY4R | P50391 | 4/20 | 0.38 |
| ▸ | NPY1R | P25929 | 3/20 | 0.38 |
| ▸ | NPY2R | P49146 | 2/20 | 0.38 |
| ▸ | NPY5R | Q15761 | 2/20 | 0.38 |
| ▸ | CNR1 | P21554 | 3/20 | 0.37 |
| ▸ | CNR2 | P34972 | 3/20 | 0.37 |
| ▸ | ANPEP | P15144 | 1/20 | 0.36 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.36 |
| ▸ | DNPEP | Q9ULA0 | 1/20 | 0.36 |
| ▸ | KCNN4 | O15554 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29549032 | 0.89 | KIF11 (0.50) | KIF11CNR1CNR2 | |
| SCHEMBL31034866 | 0.89 | KIF11 (0.50) | KIF11CNR1CNR2 | |
| SCHEMBL29549080 | 0.89 | KIF11 (0.50) | KIF11CNR1CNR2 | |
| Arginine SCHEMBL26914670 | 0.79 | KIF11 (0.46) | KIF11NPY4RNPY1RNPY2RNPY5R | |
| Arginine SCHEMBL28268971 | 0.79 | OTC (0.53) | — | |
| Arginine SCHEMBL16879777 | 0.78 | KIF11 (0.47) | KIF11NPY4RNPY1RNPY2RNPY5R | |
| Arginine SCHEMBL1287134 | 0.78 | OTC (0.43) | KIF11 | |
| Arginine SCHEMBL4606883 | 0.78 | F10 (0.44) | KIF11 | |
| SCHEMBL8768680 | 0.78 | LTA4H (0.47) | NPY4RNPY1RNPY2RNPY5RANPEP | |
| Arginine SCHEMBL12006798 | 0.78 | OTC (0.43) | KIF11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109477094-B | Peptide compounds | 武田药品工业株式会社 | 2022-04-26 | — | — | CN | disclosed |